192 related articles for article (PubMed ID: 18288635)
1. PU.1 and NFATc1 mediate osteoclastic induction of the mouse beta3 integrin promoter.
Crotti TN; Sharma SM; Fleming JD; Flannery MR; Ostrowski MC; Goldring SR; McHugh KP
J Cell Physiol; 2008 Jun; 215(3):636-44. PubMed ID: 18288635
[TBL] [Abstract][Full Text] [Related]
2. NFATc1 regulation of the human beta3 integrin promoter in osteoclast differentiation.
Crotti TN; Flannery M; Walsh NC; Fleming JD; Goldring SR; McHugh KP
Gene; 2006 May; 372():92-102. PubMed ID: 16513293
[TBL] [Abstract][Full Text] [Related]
3. Nuclear factor of activated T cells c1 induces osteoclast-associated receptor gene expression during tumor necrosis factor-related activation-induced cytokine-mediated osteoclastogenesis.
Kim K; Kim JH; Lee J; Jin HM; Lee SH; Fisher DE; Kook H; Kim KK; Choi Y; Kim N
J Biol Chem; 2005 Oct; 280(42):35209-16. PubMed ID: 16109714
[TBL] [Abstract][Full Text] [Related]
4. Cooperation of PU.1 With IRF8 and NFATc1 Defines Chromatin Landscapes During RANKL-Induced Osteoclastogenesis.
Izawa N; Kurotaki D; Nomura S; Fujita T; Omata Y; Yasui T; Hirose J; Matsumoto T; Saito T; Kadono Y; Okada H; Miyamoto T; Tamura T; Aburatani H; Tanaka S
J Bone Miner Res; 2019 Jun; 34(6):1143-1154. PubMed ID: 30721543
[TBL] [Abstract][Full Text] [Related]
5. Involvement of PU.1 in NFATc1 promoter function in osteoclast development.
Ishiyama K; Yashiro T; Nakano N; Kasakura K; Miura R; Hara M; Kawai F; Maeda K; Tamura N; Okumura K; Ogawa H; Takasaki Y; Nishiyama C
Allergol Int; 2015 Jul; 64(3):241-7. PubMed ID: 26117255
[TBL] [Abstract][Full Text] [Related]
6. MITF and PU.1 recruit p38 MAPK and NFATc1 to target genes during osteoclast differentiation.
Sharma SM; Bronisz A; Hu R; Patel K; Mansky KC; Sif S; Ostrowski MC
J Biol Chem; 2007 May; 282(21):15921-9. PubMed ID: 17403683
[TBL] [Abstract][Full Text] [Related]
7. Induction of DC-STAMP by alternative activation and downstream signaling mechanisms.
Yagi M; Ninomiya K; Fujita N; Suzuki T; Iwasaki R; Morita K; Hosogane N; Matsuo K; Toyama Y; Suda T; Miyamoto T
J Bone Miner Res; 2007 Jul; 22(7):992-1001. PubMed ID: 17402846
[TBL] [Abstract][Full Text] [Related]
8. Identification of NFAT binding sites that mediate stimulation of cathepsin K promoter activity by RANK ligand.
Balkan W; Martinez AF; Fernandez I; Rodriguez MA; Pang M; Troen BR
Gene; 2009 Oct; 446(2):90-8. PubMed ID: 19563866
[TBL] [Abstract][Full Text] [Related]
9. Myocyte enhancer factor 2 and microphthalmia-associated transcription factor cooperate with NFATc1 to transactivate the V-ATPase d2 promoter during RANKL-induced osteoclastogenesis.
Feng H; Cheng T; Steer JH; Joyce DA; Pavlos NJ; Leong C; Kular J; Liu J; Feng X; Zheng MH; Xu J
J Biol Chem; 2009 May; 284(21):14667-76. PubMed ID: 19321441
[TBL] [Abstract][Full Text] [Related]
10. Contribution of nuclear factor of activated T cells c1 to the transcriptional control of immunoreceptor osteoclast-associated receptor but not triggering receptor expressed by myeloid cells-2 during osteoclastogenesis.
Kim Y; Sato K; Asagiri M; Morita I; Soma K; Takayanagi H
J Biol Chem; 2005 Sep; 280(38):32905-13. PubMed ID: 16046394
[TBL] [Abstract][Full Text] [Related]
11. Genetic and physical interactions between Microphthalmia transcription factor and PU.1 are necessary for osteoclast gene expression and differentiation.
Luchin A; Suchting S; Merson T; Rosol TJ; Hume DA; Cassady AI; Ostrowski MC
J Biol Chem; 2001 Sep; 276(39):36703-10. PubMed ID: 11481336
[TBL] [Abstract][Full Text] [Related]
12. Isoproterenol Increases RANKL Expression in a ATF4/NFATc1-Dependent Manner in Mouse Osteoblastic Cells.
Baek K; Park HJ; Baek JH; Kim HR
Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29053621
[TBL] [Abstract][Full Text] [Related]
13. Critical roles of c-Jun signaling in regulation of NFAT family and RANKL-regulated osteoclast differentiation.
Ikeda F; Nishimura R; Matsubara T; Tanaka S; Inoue J; Reddy SV; Hata K; Yamashita K; Hiraga T; Watanabe T; Kukita T; Yoshioka K; Rao A; Yoneda T
J Clin Invest; 2004 Aug; 114(4):475-84. PubMed ID: 15314684
[TBL] [Abstract][Full Text] [Related]
14. The hematopoietic transcription factor PU.1 regulates RANK gene expression in myeloid progenitors.
Kwon OH; Lee CK; Lee YI; Paik SG; Lee HJ
Biochem Biophys Res Commun; 2005 Sep; 335(2):437-46. PubMed ID: 16083856
[TBL] [Abstract][Full Text] [Related]
15. ATF3 modulates calcium signaling in osteoclast differentiation and activity by associating with c-Fos and NFATc1 proteins.
Jeong BC; Kim JH; Kim K; Kim I; Seong S; Kim N
Bone; 2017 Feb; 95():33-40. PubMed ID: 27829167
[TBL] [Abstract][Full Text] [Related]
16. RANK ligand signaling modulates the matrix metalloproteinase-9 gene expression during osteoclast differentiation.
Sundaram K; Nishimura R; Senn J; Youssef RF; London SD; Reddy SV
Exp Cell Res; 2007 Jan; 313(1):168-78. PubMed ID: 17084841
[TBL] [Abstract][Full Text] [Related]
17. Receptor activator of nuclear factor-kappaB ligand-induced nuclear factor of activated T cells (C1) autoregulates its own expression in osteoclasts and mediates the up-regulation of tartrate-resistant acid phosphatase.
Fretz JA; Shevde NK; Singh S; Darnay BG; Pike JW
Mol Endocrinol; 2008 Mar; 22(3):737-50. PubMed ID: 18063694
[TBL] [Abstract][Full Text] [Related]
18. Complex regulation of tartrate-resistant acid phosphatase (TRAP) expression by interleukin 4 (IL-4): IL-4 indirectly suppresses receptor activator of NF-kappaB ligand (RANKL)-mediated TRAP expression but modestly induces its expression directly.
Yu M; Moreno JL; Stains JP; Keegan AD
J Biol Chem; 2009 Nov; 284(47):32968-79. PubMed ID: 19801646
[TBL] [Abstract][Full Text] [Related]
19. MHC class II transactivator negatively regulates RANKL-mediated osteoclast differentiation by downregulating NFATc1 and OSCAR.
Kim JH; Kim K; Youn BU; Jin HM; Kim N
Cell Signal; 2010 Sep; 22(9):1341-9. PubMed ID: 20466061
[TBL] [Abstract][Full Text] [Related]
20. Sp1/Sp3 and PU.1 differentially regulate beta(5) integrin gene expression in macrophages and osteoblasts.
Feng X; Teitelbaum SL; Quiroz ME; Cheng SL; Lai CF; Avioli LV; Ross FP
J Biol Chem; 2000 Mar; 275(12):8331-40. PubMed ID: 10722663
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
